Breast cancer is related to hormone replacement therapy

A recent study by scientists from the Canadian Cancer Society demonstrates a reduced incidence of breast cancer in menopausal women is associated with a reduction in the use of hormone replacement therapy.

Photos are for illustrative purposes only.(internet source)

Hormone replacement therapy is the therapy through the addition of estrogen and progesterone to slow down menopausal symptoms and aging in women.

In 2002, a large-scale clinical trial in the US showed that hormone replacement therapy increased the risk of breast cancer, heart disease and stroke.

Scientists conducted a survey of 1,200 women aged 50 to 69. Results from 2002 to 2004 showed that breast cancer cases in these women were reduced to about 10. %

According to scientists, reducing the use of hormone replacement therapy has been linked to a reduction in the incidence of cancer in Canadian women aged 50 to 69.

This finding has proven relevant studies in the United States and other countries before, which means that the rate of breast cancer development decreases with women stopping using hormone replacement therapy.

However, scientists have not yet completely determined how hormone replacement therapy affects the rate of breast cancer development.